Prelude Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-202,015
| Closed | -$4.87M | – | 1407 |
|
|
2023
Q1 | $4.87M | Buy |
+202,015
| New | +$4.87M | 0.29% | 60 |
|
|
2022
Q3 | – | Sell |
-12,064
| Closed | -$48K | – | 1931 |
|
|
2022
Q2 | $48K | Buy |
+12,064
| New | +$48K | ﹤0.01% | 1266 |
|
|
2021
Q3 | – | Sell |
-11,300
| Closed | -$95K | – | 1842 |
|
|
2021
Q2 | $95K | Buy |
+11,300
| New | +$95K | ﹤0.01% | 1209 |
|